Study Finds 40% of Chronic Pancreatitis Patients Have EPI

A meta-analysis of 14 studies pooling 7,663 patients estimates exocrine pancreatic insufficiency prevalence at 40.0%.

Updated on Nov. 19, 2026 in Diabetes

Study Finds 40% of Chronic Pancreatitis Patients Have EPI

A systematic review and meta-analysis published in the Journal of Pancreatology estimates that 40.0% of chronic pancreatitis patients have exocrine pancreatic insufficiency (EPI), with a 95% confidence interval of 33.5% to 46.7%. The analysis synthesized 14 studies covering 7,663 patients.

Why it matters

EPI impairs the body's ability to digest fat and nutrients, and the pooled estimate suggests a substantial share of chronic pancreatitis patients may go unrecognized or under-treated. Identifying smoking, low body mass index, male sex, and diabetes as associated risk factors may help clinicians target screening.

The pooled estimate of 40.0% derives from 14 studies and 7,663 patients, but detection rates varied widely by diagnostic test, from 21.1% with fecal fat testing to 52.1% with fecal elastase-1. Heterogeneity across the included studies was very high (I² = 96.713%), so the pooled figure should be read as an approximate summary.

The players

Journal of Pancreatology

A peer-reviewed medical journal focused on research into diseases of the pancreas, including pancreatitis and exocrine insufficiency.

The details

Researchers searched PubMed, Embase, Cochrane Library, and Web of Science for English-language articles published between November 27, 2004, and November 27, 2024, and pooled results using random-effects meta-analysis in STATA 18.0. The analysis also identified smoking as a risk factor for EPI in chronic pancreatitis, with an odds ratio of 1.51.

Timeline

  1. November 27, 2004 to November 27, 2024: literature search window for included studies.

  2. September 2026: review published in Journal of Pancreatology, Volume 9, Issue 3.

Health Landscape

This meta-analysis adds a regionally stratified estimate to the body of pooled research on EPI in chronic pancreatitis, showing prevalence of 31.3% in Asia, 39.8% in North America, and 44.5% in Europe. Because EPI is frequently underdiagnosed, the estimate bears on how widely pancreatic enzyme assessment is used in routine chronic pancreatitis care.

Patients with chronic pancreatitis who experience greasy stools, weight loss, or unexplained digestive symptoms may benefit from asking their clinician about EPI testing. The study's test-by-test variation suggests that the choice of diagnostic test may influence whether EPI is detected.

The takeaway

Exocrine pancreatic insufficiency appears common among chronic pancreatitis patients, and smoking and low body mass index are among the factors associated with it. Clinicians and patients may find it useful to consider EPI when digestive symptoms persist.

Further reading

For related coverage of metabolic and digestive conditions, see Diabetes.

More information

Read the full Journal of Pancreatology meta-analysis on exocrine pancreatic insufficiency prevalence.

Source note: This article includes information reported by News-Medical.